Bone Therapeutics: Funding, Investors & Team (Oct 2026)
Bone Therapeutics is a leading international biopharmaceutical company focused on innovative cell therapy products for the treatment of bone diseases. Utilizing the Company's unique knowledge of the bone/joint physiology and long-standing expertise in cell therapy and cell transplantation, Bone Therapeutics has created a fully integrated business with an advanced product pipeline comprising novel bone cell products, tailored in-house production methods, and minimally invasive treatment techniques.
Bone Therapeutics has raised $22.7M across 2 funding rounds on record, the most recent a Post-IPO Equity of $3.7M announced in Dec 2021.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Bone Therapeutics Company Profile and Key Stats
Latest funding round on record: Dec 2021.
Bone Therapeutics Funding Rounds
Bone Therapeutics raised $19.0M in a Post-IPO Debt announced in Jul 2021.
5 months later, a Post-IPO Equity of $3.7M was announced in Dec 2021.
Bone Therapeutics Founders and Leadership Team
Contact details for the Bone Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Bone Therapeutics Funding Compared to Other Biotechnology Startups
Bone Therapeutics' latest round of $3.7M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Bone Therapeutics in Biotechnology and Gosselies
Companies Similar to Bone Therapeutics
Turning biomass residues into fit-for-purpose microbial fertilizers, biostimulants and biocontrols.
A biopharmaceutical business called Novadip Biosciences was established with the goal of creating,…
Amyl therapeutics is a preclinical-stage biotechnology company pioneering a breakthrough approach to treating…
MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein…
Nyxoah is a health-technology company focused on the development and commercialization of innovative…
Coultreon Biopharma is developing best-in-class therapeutics that target clinically validated pathways in…
neuroClues provides easy-to-use eye-tracking environment to help practitioners instantaneously quantify their…
Trince is advancing cell-based science and therapeutics by facilitating the delivery of molecules into cells,…
Confo Therapeutics is a company focused on drug discovery, specifically targeting GPCRs to address medical…
Animab is a biotech company that focuses on developing unique technology to enhance the health of livestock.…
Augustine Therapeutics company is conducting two drug discovery programs in order to discover new generations…
4Tissue is a company focused on research and clinical trials that creates remedies to address the challenges…
Bone Therapeutics Funding FAQs
What does Bone Therapeutics do?
Bone Therapeutics is a leading international biopharmaceutical company focused on innovative cell therapy products for the treatment of bone diseases. Utilizing the Company's unique knowledge of the bone/joint physiology and long-standing expertise in cell therapy and cell transplantation, Bone Therapeutics has created a fully integrated business with an advanced product pipeline comprising novel bone cell products, tailored in-house production methods, and minimally invasive treatment techniques.
How much funding has Bone Therapeutics raised?
Bone Therapeutics has raised $22.7M across 2 rounds on record. The most recent is a Post-IPO Equity of $3.7M announced in Dec 2021.
When did Bone Therapeutics last raise funding?
Bone Therapeutics' most recent funding round on record is a Post-IPO Equity of $3.7M, announced in Dec 2021.
Who is the CEO of Bone Therapeutics?
Miguel Forte is listed as CEO at Bone Therapeutics.
Where is Bone Therapeutics headquartered?
Bone Therapeutics is based in Gosselies, Hainaut, Belgium.
How many employees does Bone Therapeutics have?
Bone Therapeutics is in the 101-250 employee band.
How does Bone Therapeutics' funding compare to other Biotechnology startups?
Bone Therapeutics' latest round of $3.7M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Bone Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Bone Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.